These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35517901)

  • 1. Carbapenem Resistant
    Qin J; Zou C; Tao J; Wei T; Yan L; Zhang Y; Wang H
    Infect Drug Resist; 2022; 15():2301-2314. PubMed ID: 35517901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem-resistant
    Huang W; Wei X; Xu G; Zhang X; Wang X
    Front Public Health; 2023; 11():1088262. PubMed ID: 36844819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections.
    Lin KY; Lauderdale TL; Wang JT; Chang SC
    J Microbiol Immunol Infect; 2016 Feb; 49(1):52-9. PubMed ID: 24662016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors and Outcomes of Patients with Carbapenem-Resistant
    Wei X; Li L; Li M; Liang H; He Y; Li S
    Infect Drug Resist; 2023; 16():337-346. PubMed ID: 36698726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and influence of carbapenem exposure on the development of carbapenem resistant Pseudomonas aeruginosa bloodstream infections and infections at sterile sites.
    Barron MA; Richardson K; Jeffres M; McCollister B
    Springerplus; 2016; 5(1):755. PubMed ID: 27386239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa.
    Tsao LH; Hsin CY; Liu HY; Chuang HC; Chen LY; Lee YJ
    J Microbiol Immunol Infect; 2018 Jun; 51(3):359-366. PubMed ID: 28988663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The impact of carbapenem-resistance
    Wei J; Zhu QL; Sun Z; Wang C
    Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):353-359. PubMed ID: 32370463
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant
    Zhen S; Zhao Y; Chen Z; Zhang T; Wang J; Jiang E; Zhang F; Mi Y; Zhu X; Han M; Xiao Z; Wang J; Feng S
    Front Cell Infect Microbiol; 2023; 13():1156651. PubMed ID: 37415825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic susceptibility pattern, risk factors, and prediction of carbapenem-resistant
    Liu Y; Xu Y; Wang S; Zeng Z; Li Z; Din Y; Liu J
    Heliyon; 2023 May; 9(5):e15724. PubMed ID: 37159707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by
    Zhen X; Stålsby Lundborg C; Sun X; Gu S; Dong H
    Antibiotics (Basel); 2020 Aug; 9(8):. PubMed ID: 32823707
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiology of carbapenem non-susceptible Pseudomonas aeruginosa isolates in Eastern Algeria.
    Meradji S; Barguigua A; Zerouali K; Mazouz D; Chettibi H; Elmdaghri N; Timinouni M
    Antimicrob Resist Infect Control; 2015; 4():27. PubMed ID: 26075066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of carbapenem-resistant Pseudomonas aeruginosa on clinical and economic outcomes in a Chinese tertiary care hospital: A propensity score-matched analysis.
    Chen Z; Xu Z; Wu H; Chen L; Gao S; Chen Y
    Am J Infect Control; 2019 Jun; 47(6):677-682. PubMed ID: 30554879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving trends among
    Thomsen J; Menezes GA; Abdulrazzaq NM; ; Moubareck CA; Senok A; Everett DB
    Front Public Health; 2023; 11():1243973. PubMed ID: 38106909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and outcomes of inpatients with carbapenem-resistant
    Yuan Q; Guo L; Li B; Zhang S; Feng H; Zhang Y; Yu M; Hu H; Chen H; Yang Q; Qu T
    Front Microbiol; 2023; 14():1137811. PubMed ID: 37260693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case-case-control study.
    Coppry M; Jeanne-Leroyer C; Noize P; Dumartin C; Boyer A; Bertrand X; Dubois V; Rogues AM
    J Antimicrob Chemother; 2019 Feb; 74(2):503-510. PubMed ID: 30376042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.
    Hu Y; Qing Y; Chen J; Liu C; Lu J; Wang Q; Zhen S; Zhou H; Huang L; Zhang R
    Microbiol Spectr; 2021 Dec; 9(3):e0134421. PubMed ID: 34817230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital.
    Zhang D; Cui K; Wang T; Shan Y; Dong H; Feng W; Ma C; Dong Y
    J Infect Dev Ctries; 2018 Aug; 12(8):642-648. PubMed ID: 31958327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical Characteristics and Survival Analysis of Carbapenem-Resistant Pseudomonas Aeruginosa Colonized or Infected Patients with Hematological Disorders].
    Shen YY; Zhao YC; Wang B; Wu DJ; Li QS; Shen YP; Shen JP; Cao JM; Lin SY; Ye BD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1192-1198. PubMed ID: 37551497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study.
    Vivo A; Fitzpatrick MA; Suda KJ; Jones MM; Perencevich EN; Rubin MA; Ramanathan S; Wilson GM; Evans ME; Evans CT
    BMC Infect Dis; 2022 May; 22(1):491. PubMed ID: 35610601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and mortality of carbapenem-resistant Pseudomonas aeruginosa bloodstream infection in haematology department: A 10-year retrospective study.
    Yuan F; Li M; Wang X; Fu Y
    J Glob Antimicrob Resist; 2024 Jun; 37():150-156. PubMed ID: 38615882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.